BioSputnik

United Kingdom
Newyork, Argyll and Bute, United Kingdom, 10002

Company profile

BioSputnik company profile

BioSputnik develops biotechnology and pharmaceutical solutions focused on RNA-based therapeutics and platform technologies for targeted drug delivery. The company explores lipid nanoparticle systems tailored for cell-specific delivery of therapeutic RNA, aiming to support early-stage therapy development. BioSputnik conducts research and development activities that span discovery, preclinical strategy, and translational planning in the life sciences domain. The organization also provides scientific and regulatory consulting, helping life science teams interpret experimental data, design development pathways, and navigate regulatory expectations for novel therapies. Engagements typically support biotechnology and pharmaceutical clients that require combined R&D insight and regulatory guidance for complex therapeutic platforms.

Business identity

Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0+
Founded
2019-01-01, Year

Headquarters

Postal code
10002
Country code
GB
Continent
Europe

Capital profile

Funding and company signals

No public funding data is available for this company.

Founders and investors

No public relation records are available.